{"news":[{"title":"Stellar Biotechnologies -- Independent KLH Toxicity & Immunogenicity Tests Complete","published":"2010-11-30 08:50:00"},{"title":"Stellar Biotechnologies Achieves Major Milestone","published":"2011-01-25 08:55:00"},{"title":"Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology","published":"2013-07-30 09:05:00"},{"title":"Stellar Biotechnologies Announces Achievement of Milestone in Cooperation With Bayer Innovation","published":"2010-09-13 08:15:00"},{"title":"Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations","published":"2012-01-04 09:10:00"},{"title":"Stellar Biotechnologies Announces CDN$ 1.05M Financing and Retires 1.66M Shares","published":"2010-09-29 13:24:00"},{"title":"Stellar Biotechnologies Announces Collaboration With Amaran Biotechnology, Inc.","published":"2013-12-12 12:01:00"},{"title":"Stellar Biotechnologies Announces Exclusive Option to License Clostridium Difficile Technology","published":"2012-04-10 09:05:00"},{"title":"Stellar Biotechnologies Announces Filing a US Letters Patent Application","published":"2012-10-04 15:19:00"},{"title":"Stellar Biotechnologies Announces Investor Relations Agreement","published":"2012-01-18 09:20:00"},{"title":"Stellar Biotechnologies Announces Joint Research on Clostridium Difficile Immunotherapy Accepted for Presentation","published":"2013-07-24 18:01:00"},{"title":"Stellar Biotechnologies Announces New Website -- www.StellarBiotechnologies.com","published":"2010-06-22 07:45:00"},{"title":"Stellar Biotechnologies Announces Patents for Clostridium Difficile Immunotherapy Technology Issued in U.S. and China","published":"2013-12-09 09:05:00"},{"title":"Stellar Biotechnologies Announces Pre-IDE Meeting With FDA","published":"2011-05-10 09:45:00"},{"title":"Stellar Biotechnologies Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter","published":"2013-03-13 09:10:00"},{"title":"Stellar Biotechnologies Announces Publication of \"Expert Review\" Article on Clostridium Difficile Vaccines","published":"2013-04-30 09:00:00"},{"title":"Stellar Biotechnologies Announces Receipt of Lead Purchase Order","published":"2011-09-20 09:10:00"},{"title":"Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability","published":"2011-12-06 09:18:00"},{"title":"Stellar Biotechnologies Announces US $488,985 Award in U.S. IRS Therapeutic Discovery Grants","published":"2010-11-04 14:46:00"},{"title":"Stellar Biotechnologies Announces a Strategic Agreement for Marketing and Sales With SAFC(R)","published":"2011-08-03 16:05:00"},{"title":"Stellar Biotechnologies Appoints John S. Sundsmo, Ph.D. to VP, Research & IP Management and Daniel C. Adelman, M.D. as Member of SAB","published":"2010-06-29 09:15:00"},{"title":"Stellar Biotechnologies Appoints Mark A. McPartland as Vice President of Corporate Development and Communications","published":"2013-11-20 09:05:00"},{"title":"Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors","published":"2013-09-25 09:05:00"},{"title":"Stellar Biotechnologies Appoints Two Members to Scientific Advisory Board","published":"2014-06-06 08:30:00"},{"title":"Stellar Biotechnologies Appoints Vice President, Business Development & Marketing","published":"2011-03-08 08:55:00"},{"title":"Stellar Biotechnologies Beginning Preclinical Testing","published":"2010-06-10 08:45:00"},{"title":"Stellar Biotechnologies Closes CDN $3.7M Private Placement","published":"2010-11-15 17:12:00"},{"title":"Stellar Biotechnologies Closes US$12 Million Private Placement Financing","published":"2013-09-23 09:05:00"},{"title":"Stellar Biotechnologies Exceeds Aquaculture Capacity Goals","published":"2013-02-19 08:05:00"},{"title":"Stellar Biotechnologies Expands Senior Leadership Roles With Two Key Appointments","published":"2013-11-05 09:05:00"},{"title":"Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations","published":"2013-02-06 10:36:00"},{"title":"Stellar Biotechnologies Files U.S. Patent Application for KLH Manufacturing Innovations","published":"2012-12-04 08:55:00"},{"title":"Stellar Biotechnologies Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study","published":"2013-10-21 09:05:00"},{"title":"Stellar Biotechnologies Issues President's Letter to Shareholders","published":"2013-08-06 09:05:00"},{"title":"Stellar Biotechnologies Issues Year-End Results and Highlights From 2013","published":"2014-01-02 09:05:00"},{"title":"Stellar Biotechnologies Launches KLH Site(TM)","published":"2012-04-25 10:47:00"},{"title":"Stellar Biotechnologies Launches New Corporate Website","published":"2014-05-02 08:00:00"},{"title":"Stellar Biotechnologies Launches Stellar KLH(TM) ELISA Test Kits","published":"2012-04-03 09:05:00"},{"title":"Stellar Biotechnologies Named 2014 TSX Venture 50(R) Company","published":"2014-02-13 09:05:00"},{"title":"Stellar Biotechnologies Pioneers Aquaculture Milestone in KLH Protein Manufacturing","published":"2013-01-22 08:55:00"},{"title":"Stellar Biotechnologies Presented at World Congress of Marine Biotechnology","published":"2012-09-26 09:45:00"},{"title":"Stellar Biotechnologies Presenting Today at 2014 TSX Venture 50(R) Spotlight Event","published":"2014-04-01 09:00:00"},{"title":"Stellar Biotechnologies Presents KLH Verification Method at Aquaculture America Conference","published":"2014-02-12 09:05:00"},{"title":"Stellar Biotechnologies Presents Phase IIB Proposal to The U.S. National Science Foundation (NSF)","published":"2011-07-06 12:58:00"},{"title":"Stellar Biotechnologies Presents Poster on KLH Achievements at Gordon Research Conference","published":"2014-03-03 09:05:00"},{"title":"Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Active Immunotherapy at Vaccine Congress","published":"2013-10-28 09:05:00"},{"title":"Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference","published":"2013-05-28 09:00:00"},{"title":"Stellar Biotechnologies Provides Quarterly Update\/Outlook and Comments on CBS News Cancer Vaccine Story","published":"2010-10-13 08:55:00"},{"title":"Stellar Biotechnologies Publishes New Corporate Profile","published":"2012-03-13 09:00:00"},{"title":"Stellar Biotechnologies Raises US$10 Million in Initial Closing of Private Placement","published":"2013-09-10 14:59:00"},{"title":"Stellar Biotechnologies Receives Extension of NSF -- TECP Grant","published":"2010-12-14 13:05:00"},{"title":"Stellar Biotechnologies Receives US$ 288,000 Payment","published":"2010-09-30 08:53:00"},{"title":"Stellar Biotechnologies Releases Corporate Video","published":"2014-05-20 08:30:00"},{"title":"Stellar Biotechnologies Releases Semi-Annual President's Letter to Shareholders","published":"2011-06-13 09:22:00"},{"title":"Stellar Biotechnologies Reports Second Quarter 2014 Financial Results and Recent Corporate Developments","published":"2014-04-10 09:00:00"},{"title":"Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments","published":"2014-07-10 08:30:00"},{"title":"Stellar Biotechnologies Reports on Annual General and Special Meeting","published":"2014-02-18 09:05:00"},{"title":"Stellar Biotechnologies Reports on Unusual Trading Activity","published":"2014-08-29 08:30:00"},{"title":"Stellar Biotechnologies Retains Stonegate for Institutional Outreach","published":"2014-05-07 08:30:00"},{"title":"Stellar Biotechnologies Submits Biological Master File to U.S. FDA for Subunit KLH","published":"2013-03-19 09:15:00"},{"title":"Stellar Biotechnologies Welcomes Malcolm Gefter, Ph. D. to Corporate and Scientific Advisory Boards","published":"2010-07-12 08:50:00"},{"title":"Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma","published":"2014-10-23 14:14:00"},{"title":"Stellar Biotechnologies to Host Corporate Update Conference Call and Webcast on December 11","published":"2013-12-03 09:05:00"},{"title":"Stellar Biotechnologies to Host Corporate Update and Second Quarter 2014 Results Conference Call on April 10","published":"2014-04-04 09:00:00"},{"title":"Stellar Biotechnologies to Present at 6th Annual LD Micro Conference December 4, 2013","published":"2013-11-25 09:05:00"},{"title":"Stellar Biotechnologies to Present at Biotech Showcase(TM) in San Francisco on January 7th, 2013","published":"2013-01-02 10:15:00"},{"title":"Stellar Biotechnologies to Present at ICAAC 2012 Conference on September 9 - 12, 2012","published":"2012-06-20 09:05:00"},{"title":"Stellar Biotechnologies to Present at ImVacS 2012 Summit on August 13-16, 2012","published":"2012-06-25 10:55:00"},{"title":"Stellar Biotechnologies to Present at LD Micro Conference in Los Angeles on December 5th, 2012","published":"2012-11-27 09:05:00"},{"title":"Stellar Biotechnologies to Present at Nobel Financial Capital Markets Ninth Annual Equity Conference January 23, 2013","published":"2013-01-17 09:35:00"},{"title":"Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference","published":"2014-09-02 12:02:00"},{"title":"Stellar Biotechnologies to Present at Rodman and Renshaw 13th Annual Global Investment Conference From September 8-10, 2013","published":"2013-08-29 09:05:00"},{"title":"Stellar Biotechnologies to Present at Two Upcoming Conferences","published":"2014-05-15 08:30:00"},{"title":"Stellar Biotechnologies to Present at the 26th Annual ROTH Capital Growth Conference","published":"2014-02-27 09:05:00"},{"title":"Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference","published":"2013-05-21 09:33:00"},{"title":"Stellar Biotechnologies' Exclusive License Agreement on Bayer Innovations\/Stellar KLH Technology","published":"2010-12-07 08:50:00"},{"title":"Stellar Biotechnologies' Shares Begin Trading on the OTCQB Market","published":"2013-01-15 13:43:00"},{"title":"Stellar Biotechnologies, Inc. Announces Meeting and Record Date and Approval of Advance Notice Policy","published":"2013-12-27 16:00:00"},{"title":"Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement","published":"2013-08-22 09:05:00"},{"title":"Stellar Biotechnologies, Inc. to Host Conference Call at 2:30 pm ET on Tuesday, December 18, 2012 to Provide Business Overview","published":"2012-12-12 09:05:00"},{"title":"Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January","published":"2014-01-06 09:05:00"},{"title":"UPDATE: Stellar Biotechnologies Files Key Patent for Company","published":"2010-09-10 13:20:00"}]}